Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Asthma
|
714 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.100 | 0.952 | 21 | 1995 | 2019 | |||||
Obesity
|
900 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.100 | 0.882 | 17 | 1997 | 2018 | |||||
Hypertensive disease
|
871 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.100 | 0.833 | 12 | 2001 | 2017 | |||||
Coronary Artery Disease
|
1022 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.050 | 0.800 | 5 | 2005 | 2018 | |||||
Myocardial Infarction
|
547 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.050 | 1.000 | 5 | 2002 | 2018 | |||||
Chronic Obstructive Airway Disease
|
301 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.040 | 1.000 | 4 | 2012 | 2019 | |||||
Congestive heart failure
|
156 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.040 | 0.750 | 4 | 2009 | 2018 | |||||
Diabetes Mellitus, Non-Insulin-Dependent
|
1598 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.040 | 1.000 | 4 | 2001 | 2003 | |||||
Cardiovascular Diseases
|
382 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.030 | 0.667 | 3 | 2005 | 2012 | |||||
Coronary heart disease
|
769 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.030 | 1.000 | 3 | 2005 | 2018 | |||||
Acute Chest Syndrome
|
135 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.020 | 1.000 | 2 | 2005 | 2017 | |||||
Acute Coronary Syndrome
|
97 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.020 | 1.000 | 2 | 2005 | 2017 | |||||
Cerebrovascular accident
|
412 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.020 | 1.000 | 2 | 2002 | 2007 | |||||
Chronic heart failure
|
11 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.020 | 1.000 | 2 | 2009 | 2011 | |||||
Coronary Arteriosclerosis
|
440 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.020 | 1.000 | 2 | 2008 | 2018 | |||||
Cystic Fibrosis
|
162 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.020 | 1.000 | 2 | 2011 | 2012 | |||||
Essential Hypertension
|
291 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.020 | 1.000 | 2 | 2010 | 2011 | |||||
Heart failure
|
120 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.020 | 0.500 | 2 | 2010 | 2018 | |||||
Hypertriglyceridemia
|
155 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.020 | 1.000 | 2 | 2001 | 2010 | |||||
Allergic sensitization
|
16 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Breast Carcinoma
|
2145 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Bronchial Hyperreactivity
|
18 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.010 | 1.000 | 1 | 2000 | 2000 | |||||
Cerebral Palsy
|
50 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||
Childhood asthma
|
79 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Chronic Kidney Diseases
|
155 | 0.597 | 0.640 | 5 | 148826910 | stop gained | G/C;T | snv | 0.68 | 0.010 | 1.000 | 1 | 2009 | 2009 |